Epitomeemedical
2 known investors
Epitomee develops ingestible capsule-based therapies that deploy in specific regions of the stomach, duodenum, and small intestine to provide mechano-sensory stimulation, targeted drug delivery, and absorption management before dissolving and passing naturally. The company partners with pharmaceutical and industry companies to commercialize these therapeutic applications.
Investors · 2
Frequently asked questions
- What does Epitomeemedical do?
- Epitomee develops ingestible capsule-based therapies that deploy in specific regions of the stomach, duodenum, and small intestine to provide mechano-sensory stimulation, targeted drug delivery, and absorption management before dissolving and passing naturally. The company partners with pharmaceutical and industry companies to commercialize these therapeutic applications.
- Who are Epitomeemedical's investors?
- Epitomeemedical's investors include Agate Medical Investments LP, XT Venture Capital.